Hybritech Incorporated develops and markets monoclonal antibodies. It is a biotechnology company that uses these antibodies to make diagnostic and medical monitoring tests to identify a variety of infectious, viral and cancer-related diseases such as colon and prostate cancer, infertility, allergies, and issues that arise during pregnancy.